Ingrezza is the brand name for valbenazine, a prescription medicine classified as a vesicular monoamine transporter 2 inhibitor. It is approved for adults with tardive dyskinesia and for chorea . . .
Multiple sclerosis is a condition in which the immune system affects the central nervous system, including the brain and spinal cord. The condition can have different patterns and symptoms, . . .
Relapsing multiple sclerosis is a condition in which periods of new or worsening neurological symptoms can occur, followed by periods of partial or complete recovery. Long term management focuses . . .
Multiple sclerosis is a condition affecting the brain and spinal cord, and its symptoms can vary considerably between individuals. Rehabilitation is not limited to a particular stage of the . . .
Multiple sclerosis (MS) is a long term condition affecting the central nervous system, particularly the brain and spinal cord. The condition can affect people differently, and symptoms may appear, . . .
Multiple sclerosis is a chronic condition affecting the central nervous system, including the brain and spinal cord. Disease modifying therapies, commonly called DMTs, are designed to influence the underlying . . .
Relapsing multiple sclerosis is a form of multiple sclerosis in which periods of neurological symptoms, known as relapses, are followed by periods of recovery or remission. Treatment is generally . . .
Multiple sclerosis is a chronic condition affecting the central nervous system, and its course can vary considerably between individuals. In relapsing forms of MS, periods of new or worsening . . .
Relapsing multiple sclerosis can involve episodes of neurological symptoms known as relapses, followed by periods of recovery or stability. Management aims to reduce disease activity and its effects on . . .
Relapsing multiple sclerosis is a form of multiple sclerosis characterized by episodes of new or worsening neurological symptoms followed by periods of improvement or remission. Treatment and disease management . . .